Good MorningThe S&P 500 struggled for direction on Tuesday despite the passage of a new stimulus bill by Congress. The bill is worth $900 billion and already facing stiff criticism due to the amount of pork and frivolous spending it includes. The average American is slated to receive just $600 of the money with many expected to receive their checks within weeks. The S&P 500 traded in a very tight range and closed with nearly no movement versus the prior session.
On the economic front, the number of existing homes sold in the month of November fell less than expected versus the previous month. The number of homes sold comes out to 6.69 million on an annualized basis and is up more than 25% on a year-over-year basis. Looking forward, the sale of homes is not expected to slacken in 2020 and will drive gains in related sectors like home improvement as well.
Featured: Could You Turn $100 into $47,350 (and KILL Verizon)? (Crowdability) 
|
Markets | | | Asian shares have declined, extending losses on growing worries over a new, potentially more infectious strain of the coronavirus that has countries around the world restricting travel from the United Kingdom Read the Full Story |
|
From Our PartnersWe Are in a Plant-based Meat Revolution and Modern Meat is Aiming to Become a Household Name in It! this could be a ground-floor situation unfolding...
| | | | Continue Reading |
|
Markets | | | Shares retreated in Asia on Tuesday after the U.S. included dozens more Chinese companies in a Commerce Department blacklist in another blow to markets already wracked with uncertainty over the pandemic.
The Shanghai Composite index dropped nearly 2% on Tuesday and other regional mar... Read the Full Story |
|
Politics | | | European shares and U.S. futures advanced Tuesday after American lawmakers approved a $900 billion package of measures to help the economy get through the pandemic.
Stocks rose in Paris, London and Frankfurt but fell in Tokyo and other Asian markets. The Shanghai Composite index drop... Read the Full Story |
|
From Our PartnersThe future isn’t meat! Eat Beyond makes it simple to invest in a new future of food and has made the first of its kind fund giving access to the best alternative food source companies in the world! | | | | Continue Reading |
|
Healthcare | | | The massive, year-end catchall bill that Congress has passed combines $900 billion in COVID-19 aid with a $1.4 trillion spending bill and reams of other unfinished legislation on taxes, energy, education and health care Read the Full Story |
|
Politics | | | People with private health insurance will see the nasty shock of “surprise” medical bills virtually gone, thanks to the coronavirus compromise passed by Congress.
The charges that can run from hundreds to tens of thousands of dollars come from doctors and hospitals that are outside th... Read the Full Story |
|
From Our PartnersPlant-based foods have become a solid growth industry. As the vegan revolution continues to boom, stocks within the space could be poised for big moves! | | | | Continue Reading |
|
Stocks | | |
As concerns around a new strain of the coronavirus have grown in recent days and the COVID relief bill has dragged on, investors took a breather yesterday from the all-time highs they’d set last week. The benchmark S&P 500 index found itself down more than 2% at one point while the Dow J... Read the Full Story |
|
Stocks | | | Special purpose acquisition company (SPAC) RMG Acquisition (NYSE: RMG) will reverse merge with Romeo Power Technology, a battery technology company accommodating the electric vehicle (EV) market. Shares have seen a boost due to the EV and SPAC mania boosted by the likes of QuantumScape Corporation (... Read the Full Story |
|
Markets | | |
For the risk-averse investor, the last several months have been like a rocket sled clear through the center of Crazy Town. Stocks that seemed to have little in the way of visible support shot up to multiples of their previous valuations, while long-term holdings began to collapse. I won't even bri... Read the Full Story |
|
Markets | | | Spaceship manufacturer Virgin Galactic Holdings, Inc. (NYSE: SPCE) stock imploded on the failure of a test flight sending shares collapsing from a high of $35.82 to a low of $23.78 in eight trading sessions. Read the Full Story |
|
Markets | | | Leslie’s (NASDAQ:LESL) has been around for about 60 years but only went public two months ago. That is surprising because the company is uniquely positioned as the largest supplier of pool and spa supplies Read the Full Story |
|
The Early Bird Stock Of The Day CRISPR Therapeutics is a gene-editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene-editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in San Francisco, California and London, United Kingdom. For more information, please visit www.crisprtx.com. | | View Today's Stock Pick |
|
